Status:

ENROLLING_BY_INVITATION

Virtual Reality for Pain and Anxiety Relief in Labor

Lead Sponsor:

University Tunis El Manar

Collaborating Sponsors:

HypnoVR

Conditions:

Labor Pain

Anxiety

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

The aim of this study is to evaluate the impact of virtual reality hypnosis technique on pain and anxiety of women during labor. We will perform a randomized controlled trial on a group of labouring w...

Detailed Description

This multicenter randomized controlled trial evaluates the effectiveness of a virtual reality hypnosis device (HypnoVR) in managing pain and anxiety during labor. Women in the latent and active phases...

Eligibility Criteria

Inclusion

  • Participants must meet all of the following criteria to be eligible for inclusion in the study:
  • Female participants aged between 18 and 45 years
  • Primiparous or multiparous
  • Singleton pregnancy
  • Cephalic (vertex) presentation
  • Gestational age between 37 and 41 completed weeks
  • Admitted in spontaneous (uninduced) labor
  • Low-risk pregnancy with no obstetric complications (e.g., no preeclampsia, gestational diabetes, or intrauterine growth restriction)
  • Spontaneous and uneventful course of pregnancy
  • At least four documented prenatal care visits during pregnancy
  • Expressed desire for vaginal delivery
  • Provided written informed consent to participate in the study

Exclusion

  • Participants will be excluded from the study if they meet any of the following criteria:
  • History of any psychiatric disorder (e.g., anxiety, depression, bipolar disorder, psychosis, delirium) organic brain disease, or cognitive/developmental disorders)
  • History of seizures or epilepsy
  • Any degree of hearing impairment
  • Any visual impairment
  • History of face, neck, or head injuries that may interfere with the use of virtual reality equipment
  • History of motion sickness or vestibular disorders (e.g., dizziness, vertigo)
  • Chronic pain conditions or frequent migraines
  • History of claustrophobia
  • High-risk pregnancy (e.g., fetal growth restriction, placenta previa, or other significant maternal-fetal complications)
  • Known fetal anomalies or placental abnormalities
  • Labor pain not attributed to uterine contractions
  • Induced labor (medically or pharmacologically initiated)

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2025

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT07194967

Start Date

May 1 2025

End Date

September 30 2025

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ben Arous regional Hospital

Ben Arous, Tunisia, 2096